About Robert Lynn MD PA
Services
Type of Care
Substance use treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Clonidine; Medication for mental disorders; Non-nicotine smoking/tobacco cessation
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
SAMHSA certification for opioid treatment program (OTP); Drug Enforcement Agency (DEA)
Payment/Insurance/Funding Accepted
Cash or self-payment
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Screening for substance use; Screening for mental disorders
Testing
Drug or alcohol urine screening
Transitional Services
Aftercare/continuing care
Recovery Support Services
Mentoring/peer support
Other Services
Treatment for other addiction disorder
Education and Counseling Services
Substance use disorder education
Facility Smoking Policy
Smoking permitted without restriction
Age Groups Accepted
Children/adolescents
Gender Accepted
Female; Male
Facility Vaping Policy
Vaping permitted without restriction
Ancillary Services
Mental health services
